Metraipolis › archive › dc_3398e64845d2

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms — Europe PMC PMID:35582225

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35582225
DOI
10.20517/cdr.2020.45
License (as archived)
solo-consultazione
Archived
2026-10-07T16:34:13.485Z
SHA-256 of the archived text
e6da7c9f35b00bcbfc0186348e56d9b31ac1a99f4336aed8c32f22d3840b3c42
Stable URL of this page
https://metraipolis.com/documento/dc_3398e64845d2

How to cite

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms — Europe PMC PMID:35582225 — Europe PMC (en), https://europepmc.org/article/MED/35582225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3398e64845d2 (Metraipolis archive dc_3398e64845d2, sha256 e6da7c9f35b00bcbfc0186348e56d9b31ac1a99f4336aed8c32f22d3840b3c42)
BibTeX
@misc{dc3398e64845d2,
  title = {Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms — Europe PMC PMID:35582225},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35582225},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3398e64845d2; sha256 e6da7c9f35b00bcbfc0186348e56d9b31ac1a99f4336aed8c32f22d3840b3c42},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35582225. Agents can read the archived copy with the MCP tool read_document.